Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02389855 · ClinicalTrials.gov registry record
Laser Ablation in Stereotactic Neurosurgery (LAISE): NeuroBlate® Retrospective Registry
A clinical trial, sponsored by Monteris Medical.
- Completed
- Registry status
- 144
- Enrollment target
NCT02389855 is a clinical trial that has completed, run by Monteris Medical. The registered enrollment target is 144 participants.
The verdict
NCT02389855 has completed, sponsored by Monteris Medical.
- COMPLETED
- Registry status
- 144 participants
- Enrollment target
Study Summary
The NeuroBlate® System (NBS), is a minimally invasive robotic laser thermotherapy tool. It employs a pulsed surgical laser to deliver targeted energy to abnormal brain tissue caused by tumors and lesions. Since receiving FDA clearance in April 2013, the NBS has been used in nearly 300 procedures conducted at approximately 20 leading institutions across the United States. This post-market, multi-center retrospective study is designed to collect long-term follow-up data on patients who were treated previously with NBS.
Interventions
- PROCEDURE NeuroBlate® System Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2015-02 |
| Est. Completion | 2016-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02389855
The ClinicalTrials.gov registry entry for NCT02389855 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Monteris Medical, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NeuroBlate® System Therapy is the first listed.
NCT02389855 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02389855 about?
NCT02389855 is a clinical study titled "Laser Ablation in Stereotactic Neurosurgery (LAISE): NeuroBlate® Retrospective Registry". The NeuroBlate® System (NBS), is a minimally invasive robotic laser thermotherapy tool. It employs a pulsed surgical laser to deliver targeted energy to abnormal brain tissue caused by tumors and lesions. Since receiving FDA clearance in April 2013, the NBS has been used in nearly 300 procedures con...
What is the current status of trial NCT02389855?
This trial is currently completed. The enrollment target is 144 participants. The study started on 2015-02. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02389855?
The interventions under investigation include: NeuroBlate® System Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT02389855?
This trial is sponsored by Monteris Medical, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.